AR013352A1 - Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica. - Google Patents
Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica.Info
- Publication number
- AR013352A1 AR013352A1 ARP980102882A ARP980102882A AR013352A1 AR 013352 A1 AR013352 A1 AR 013352A1 AR P980102882 A ARP980102882 A AR P980102882A AR P980102882 A ARP980102882 A AR P980102882A AR 013352 A1 AR013352 A1 AR 013352A1
- Authority
- AR
- Argentina
- Prior art keywords
- diabetes mellitus
- insulin sensitizer
- preparation
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712865.6A GB9712865D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
GBGB9806708.5A GB9806708D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013352A1 true AR013352A1 (es) | 2000-12-27 |
Family
ID=26311746
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102885A AR014881A1 (es) | 1997-06-18 | 1998-06-17 | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agente |
ARP980102882A AR013352A1 (es) | 1997-06-18 | 1998-06-17 | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102885A AR014881A1 (es) | 1997-06-18 | 1998-06-17 | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agente |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0975343A1 (no) |
JP (1) | JP2001523271A (no) |
KR (1) | KR20010013845A (no) |
CN (1) | CN1274282A (no) |
AP (1) | AP9901720A0 (no) |
AR (2) | AR014881A1 (no) |
AU (1) | AU8799998A (no) |
BG (1) | BG103966A (no) |
BR (1) | BR9810186A (no) |
CA (1) | CA2294134A1 (no) |
CO (1) | CO4940453A1 (no) |
DZ (1) | DZ2519A1 (no) |
EA (1) | EA200000040A1 (no) |
IL (1) | IL133138A0 (no) |
MA (1) | MA26510A1 (no) |
NO (1) | NO996270L (no) |
NZ (1) | NZ501345A (no) |
OA (1) | OA11631A (no) |
PE (1) | PE89199A1 (no) |
PL (1) | PL337577A1 (no) |
SK (1) | SK179499A3 (no) |
TR (1) | TR199903072T2 (no) |
UY (1) | UY25051A1 (no) |
WO (1) | WO1998057635A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0009934A (pt) | 1999-04-23 | 2002-06-04 | Smithkline Beecham Plc | Produto farmacêutico |
CN100577175C (zh) | 2001-04-04 | 2010-01-06 | 奥索-麦克尼尔药品公司 | 包括葡萄糖重吸收抑制剂和ppar调节剂的联合疗法 |
US6838442B2 (en) | 2001-04-04 | 2005-01-04 | Ortho-Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators |
FR2832930A1 (fr) * | 2001-12-03 | 2003-06-06 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
JP2004067575A (ja) * | 2002-08-06 | 2004-03-04 | Yaizu Suisankagaku Industry Co Ltd | 糖尿病治療薬効果促進剤 |
CN101121004B (zh) * | 2006-08-08 | 2010-07-21 | 鲁南制药集团股份有限公司 | 含有胰岛素增敏剂和米格列醇的药物组合物 |
CN101584705B (zh) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
CN101584688B (zh) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0601001T3 (da) * | 1991-08-26 | 1997-10-20 | Upjohn Co | Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre. |
US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1998
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-15 CN CN98806319A patent/CN1274282A/zh active Pending
- 1998-06-15 JP JP50375699A patent/JP2001523271A/ja not_active Ceased
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/pt not_active IP Right Cessation
- 1998-06-15 PL PL98337577A patent/PL337577A1/xx unknown
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Application Discontinuation
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/xx unknown
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 EA EA200000040A patent/EA200000040A1/ru unknown
- 1998-06-15 IL IL13313898A patent/IL133138A0/xx unknown
- 1998-06-15 SK SK1794-99A patent/SK179499A3/sk unknown
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/ko not_active Application Discontinuation
- 1998-06-17 MA MA25121A patent/MA26510A1/fr unknown
- 1998-06-17 AR ARP980102885A patent/AR014881A1/es unknown
- 1998-06-17 AR ARP980102882A patent/AR013352A1/es unknown
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/xx active
- 1998-06-18 UY UY25051A patent/UY25051A1/es not_active Application Discontinuation
- 1998-06-18 PE PE1998000536A patent/PE89199A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/es unknown
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
-
1999
- 1999-12-08 BG BG103966A patent/BG103966A/bg unknown
- 1999-12-17 NO NO996270A patent/NO996270L/no not_active Application Discontinuation
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL133138A0 (en) | 2001-03-19 |
EA200000040A1 (ru) | 2000-08-28 |
NO996270D0 (no) | 1999-12-17 |
OA11631A (en) | 2004-11-22 |
JP2001523271A (ja) | 2001-11-20 |
NZ501345A (en) | 2001-10-26 |
MA26510A1 (fr) | 2004-12-20 |
EP0975343A1 (en) | 2000-02-02 |
PL337577A1 (en) | 2000-08-28 |
WO1998057635A1 (en) | 1998-12-23 |
UY25051A1 (es) | 2000-09-29 |
AU8799998A (en) | 1999-01-04 |
PE89199A1 (es) | 1999-10-23 |
KR20010013845A (ko) | 2001-02-26 |
SK179499A3 (en) | 2000-11-07 |
CN1274282A (zh) | 2000-11-22 |
AP9901720A0 (en) | 1999-12-31 |
BR9810186A (pt) | 2000-08-08 |
TR199903072T2 (xx) | 2000-07-21 |
NO996270L (no) | 1999-12-17 |
AR014881A1 (es) | 2001-04-11 |
CO4940453A1 (es) | 2000-07-24 |
BG103966A (bg) | 2000-07-31 |
CA2294134A1 (en) | 1998-12-23 |
DZ2519A1 (fr) | 2003-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012998A1 (es) | Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprende dichosensibilizador y dicho agente. | |
UY25799A1 (es) | Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina y otro agente antidiabético. | |
CL2009001899A1 (es) | Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01). | |
AR033688A1 (es) | Composicion parenteral reconstituible | |
UY25798A1 (es) | Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina tiazolidinadiónico. | |
BR9810445A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida | |
AR013352A1 (es) | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica. | |
AR015894A1 (es) | Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos | |
AR012996A1 (es) | Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador. | |
AR016350A1 (es) | Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos | |
AR016768A1 (es) | COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS | |
AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional | |
AR007058A1 (es) | Uso de interferon en medicamentos y composiciones para contacto oromucosal | |
ECSP982541A (es) | Nuevo metodo de tratamiento ii | |
ECSP982535A (es) | Nuevo metodo de tratamiento (i) | |
ECSP982591A (es) | Nuevo metodo de tratamiento iv | |
ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
ECSP993215A (es) | Nueva composicion y uso | |
ECSP982592A (es) | Nuevo metodo de tratamiento v | |
CO5270004A1 (es) | Composiciones farmaceuticas con agente del tipo biguanida para tratamientos en diabetes | |
AR010343A1 (es) | Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica. | |
RU94019942A (ru) | Фармацевтическая композиция для повышения проницаемости кожи для улучшенной локальной доставки лекарств | |
AP1692A (en) | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent. | |
ECSP993216A (es) | Nueva composicion y uso ii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |